Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INVL Technology Governance Information 2025

Apr 8, 2025

2265_rns_2025-04-08_3e03cea3-4253-486d-b335-2a042491d6cb.pdf

Governance Information

Open in viewer

Opens in your device viewer

INVL

TECHNOLOGY

img-0.jpeg

Tomas Bubinas –

Member of the Audit Committee (should maintain independent status in accordance with legal acts until 23 December 2026)

The term of office Since 2025 till 2029
Educational background and qualifications 2004 - 2005 Baltic Management Institute (BMI), Executive MBA
1997 - 2000 Association of Chartered Certified Accountants. ACCA. Fellow Member
1997 Lithuanian Sworn Registered Auditor
1988 - 1993 Vilnius University, Msc. in Economics
Work experience Since 2022 individual consulting activities
2013 – 2022 Chief Operating Officer at Biotechpharma, UAB
2010 - 2012 Senior Director, Operations. TEVA Biopharmaceuticals (USA)
2004 - 2010 Chief Financial Officer for Baltic countries, Teva Pharmaceuticals
2001 - 2004 m. Chief Financial Officer, Sicor Biotech
1999 - 2001 Senior Manager, PricewaterhouseCoopers
1994 - 1999 Senior Auditor, Manager, Coopers & Lybrand.

img-1.jpeg

Dangutė Pranckėnienė –

Independent Member of the Audit Committee

The term of office Since 2025 till 2029
Educational background and qualifications 1995 - 1996 Vilnius Gediminas Technical University, Master of Business Administration.
1976 - 1981 Vilnius University, Master of Economics.
The International Coach Union (ICU), professional coucher name, license No. E-51.
Lithuanian Ministry of Finance, the auditor's name, license No. 000345.
Work experience Since 1997 the Partner at Moore Mackonis, UAB (previous name Moore Stephens Vilnius and Verslo auditas)
1996 - 1997 Audit Manager, Deloitte & Touche
1995 - 1996 Lecturer, Vilnius Gediminas Technical University
1982 - 1983 Lecturer, Vilnius University

img-2.jpeg

Andrius Lenickas –

Independent Member of the Audit Committee

The term of office Since 2025 till 2029

Specialioji uždarojo tipo privataus kapitalo investicinė bendrovė „INVL Technology"
Gynėjų g. 14, LT-01110 Vilnius
Tel. +370 5 279 0601;
El. p. [email protected]
Įmonės kodas 300893533
A.s. LT66 7044 0600 0604 2883
SEB bankas
Registro tvarkytojas VĮ Registrų centras


INL

TECHNOLOGY

| Educational background and qualifications | Baltic Management Institute (BMI), Executive MBA
Association of Chartered Certified Accountants. ACCA. Diploma
Lithuanian Sworn Registered Auditor
Vilnius University, Msc. in Economics |
| --- | --- |
| Work experience | Since 2023 founder and director, UAB Lea finansai
2013 - 2022, Chief Financial Officer and Head of Administration of the Group, UAB AL holdingas
2010 - 2013 - Chief Executive Officer, UAB Euroapotheca.
2007 – 2010 Chief Financial Officer for the Baltic States, UAB Sanofi Lietuva
2002 – 2006 Chief Financial Officer and Head of Administration of Lawin Law Firm (currently Eliex Valiūnas).
1999 - 2001 Senior Auditor, Manager, PricewaterhouseCoopers UK
1996 - 1999 Auditor, Senior Auditor, Coopers & Lybrand
1993-1995 Customer manager, Balticbankas |

Specialiōji uždarojo tipo privataus kapitalo investicinė bendrovė „INVL Technology“
Gynėjų g. 14, LT-01110 Vilnius
Tel. +370 5 279 0601;
El. p. [email protected]

Įmonės kodas 300893533
A.s. LT66 7044 0600 0604 2883
SEB bankas
Registro tvarkytojas VĮ Registrų centras